APLS
Apellis Pharmaceuticals, Inc. Common Stock
$21.76
-1.05%
-0.23
Notify me if price changes either direction
Buy APLS stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
2.8B
Enterprise value
2.8B
Trailing PE
61.111107
Forward PE
-16.429068
PEG Ratio
-0.12954428211982
Enterprise to EBITDA
33.852
Enterprise to revenue
2.734
Price to book MRQ
6.9378743
Price to sales TTM
2.7386491
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
1.0B
EBITDA
82.1M
Diluted EPS TTM
0.36
Total Cash (MRQ)
480.2M
Current ratio (MRQ)
3.544
Operating Cash Flow (TTM)
78.9M
APLS trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
January 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
